Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects
Public ClinicalTrials.gov record NCT00125346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Trial to Assess the Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis (CF) Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Lung infections are a chronic problem for patients with cystic fibrosis (CF). Some patients with CF may have a type of bacteria called Pseudomonas aeruginosa in their lungs that can cause infections or make their symptoms worse. Tobramycin inhalation solution (TOBI) is an approved antibiotic, which is inhaled directly into the lungs, and can be used to manage these infections. Tobramycin inhalation powder (TIP) is a new, experimental powder formulation of tobramycin that is inhaled directly into the lungs using a T-326 inhaler. The purpose of this research study is to determine if TIP is safe and effective when compared to placebo (a powder with no medicine) treatment.
Study identification
- NCT ID
- NCT00125346
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 98 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2005 (Type not available)
- Primary completion
- Feb 2007 (Actual)
- Completion
- Feb 2007 (Actual)
- Last update posted
- Oct 12, 2011
2005 – 2007
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| For information on a site near you, call 1-800-244-7668 Option "2" | Mobile | Alabama | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Phoenix | Arizona | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Fresno | California | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Long Beach | California | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Los Angeles | California | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Oakland | California | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Sacramento | California | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Orlando | Florida | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Pensacola | Florida | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Atlanta | Georgia | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Augusta | Georgia | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Chicago | Illinois | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Oak Lawn | Illinois | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Ann Arbor | Michigan | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | New Hyde Park | New York | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | New York | New York | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Valhalla | New York | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Durham | North Carolina | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Cleveland | Ohio | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Columbus | Ohio | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Oklahoma City | Oklahoma | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Philadelphia | Pennsylvania | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Charleston | South Carolina | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Tyler | Texas | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Salt Lake City | Utah | — | — |
| For information on a site near you, call 1-800-244-7668 Option "2" | Morgantown | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00125346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 12, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00125346 live on ClinicalTrials.gov.